0
0
Data Make It Clear: SGLT2 Inhibitors Can Be Used in Most Common Kidney Diagnoses, Says Dr William G. Herrington - AJMC.com Managed Markets Network
+ 40 more
11/4/23 at 1:03pm
Organization
Ajmc.com
Authors
Laura Joszt MA Gillian McGovern
59 words
0
Comments
Data shows sodium-glucose cotransporter-2 (SGLT2) inhibitors are efficacious and can be used in almost all common kidney diagnoses, explained William G. Herrington, MD, MA, MBBS, Nuffield Department of Population Health, University of Oxford.
You are the first to view
https://www.ajmc.com/view/data-make-it-clear-sglt2-inhibitors-can-be-used-in-most-common-kidney-diagnoses-says-dr-william-g-herrington
Create an account or login to join the discussion